InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
79.75
(
0.00%
)
Bitcoin
68,983.94
(
1.58%
)
Post# of 214
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

gfp927z

Send PM Follow Ignore
Followers 85
Posts 32891
Boards Moderated 86
Alias Born 03/22/2005

gfp927z

Re: None

Sunday, 07/10/2022 10:19:47 AM

Sunday, July 10, 2022 10:19:47 AM

Post# of 214
Else Nutrition - interview with the CEO discussing the recent financing (link below). Among other things, it looks like the clinical trials required by the FDA have become more expensive than expected. She said these clinical trials should start in the next several months.

Having the future of the company so dependent upon clinical trials and the FDA tends to give BABYF the risk profile of a biotech stock, at least for now -


https://themarketherald.ca/else-nutrition-announces-closing-of-7-35-million-marketed-public-offering-2022-07-04/

<<<



---
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up